AJP - Regulatory, Integrative and Comparative Physiology, Vol 272, Issue 1 234-R242, Copyright © 1997 by American Physiological Society

ARTICLES

Adrenomedullin-(22-52) antagonizes vasodilator responses to CGRP but not adrenomedullin in the cat

H. C. Champion, J. A. Santiago, W. A. Murphy, D. H. Coy and P. J. Kadowitz
Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana 70112, USA.

The effects of adrenomedullin (ADM)-(22-52), a putative ADM receptor antagonist, on vasodilator responses to ADM and the structurally related peptide, calcitonin gene-related peptide (CGRP), were investigated in the hindlimb vascular bed of the cat under constant-flow conditions. ADM-(22-52) had no significant effect on hindlimb perfusion pressure when injected in doses up to 120 nmol; after administration of ADM-(22-52), vasodilator responses to ADM were unchanged, whereas vasodilator responses to CGRP were inhibited. The inhibitory effects of ADM-(22-52) on responses to CGRP were selective and reversible and were similar to the inhibitory effects of the CGRP antagonist CGRP-(8-37). Hindlimb vasodilator responses to CGRP and to ADM were increased in duration by the adenosine 3',5'-cyclic monophosphate (cAMP) phosphodiesterase inhibitor rolipram but were not altered by inhibitors of guanosine 3',5'-cyclic monophosphate phosphodiesterase, nitric oxide synthetase, K(+)-ATP channels, the cyclooxygenase pathway, or the adrenergic nervous system. These results demonstrate that ADM-(22-52) is a selective CGRP receptor antagonist in the hindlimb vascular bed of the cat. The present data suggest that vasodilator responses to CGRP and ADM are mediated by different receptors but that these peptides dilate the hindlimb vascular bed of the cat by a similar cAMP-dependent mechanism.

This article has been cited by other articles:

				S. D. Brain and A. D. Grant Vascular Actions of Calcitonin Gene-Related Peptide and Adrenomedullin Physiol Rev, July 1, 2004; 84(3): 903 - 934. [Abstract] [Full Text] [PDF]

				H. C. Champion, T. J. Bivalacqua, R. L. Pierce, W. A. Murphy, D. H. Coy, A. L. Hyman, and P. J. Kadowitz Responses to human CGRP, ADM, and PAMP in human thymic arteries Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2003; 284(2): R531 - R537. [Abstract] [Full Text] [PDF]

				D. R. Poyner, P. M. Sexton, I. Marshall, D. M. Smith, R. Quirion, W. Born, R. Muff, J. A. Fischer, and S. M. Foord International Union of Pharmacology. XXXII. The Mammalian Calcitonin Gene-Related Peptides, Adrenomedullin, Amylin, and Calcitonin Receptors Pharmacol. Rev., June 1, 2002; 54(2): 233 - 246. [Abstract] [Full Text] [PDF]

				H. C. Champion, T. J. Bivalacqua, K. Toyoda, D. D. Heistad, A. L. Hyman, and P. J. Kadowitz In Vivo Gene Transfer of Prepro-Calcitonin Gene-Related Peptide to the Lung Attenuates Chronic Hypoxia-Induced Pulmonary Hypertension in the Mouse Circulation, February 29, 2000; 101(8): 923 - 930. [Abstract] [Full Text] [PDF]

				H. Hayakawa, Y. Hirata, M. Kakoki, Y. Suzuki, H. Nishimatsu, D. Nagata, E. Suzuki, K. Kikuchi, T. Nagano, K. Kangawa, et al. Role of Nitric Oxide–cGMP Pathway in Adrenomedullin-Induced Vasodilation in the Rat Hypertension, February 1, 1999; 33(2): 689 - 693. [Abstract] [Full Text] [PDF]

				T. Nishikimi, T. Horio, T. Sasaki, F. Yoshihara, S. Takishita, A. Miyata, H. Matsuo, and K. Kangawa Cardiac Production and Secretion of Adrenomedullin Are Increased in Heart Failure Hypertension, December 1, 1997; 30(6): 1369 - 1375. [Abstract] [Full Text]